Exploiting relationships between outcomes in Bayesian multivariate network meta‐analysis with an application to relapsing‐remitting multiple sclerosis

Bivariate network meta‐analysis for surrogate endpoint evaluation

(2019) Sylwia Bujkiewicz et al.   STATISTICS IN MEDICINE

057 Real world evidence (RWE) on long-term persistence of fingolimod in relapsing-remitting multiple sclerosis (RRMS) in australia

(2018) Robert Walker et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples

(2017) Richard D Riley et al.   BMJ-British Medical Journal

Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples

(2017) Richard D Riley et al.   BMJ-British Medical Journal

Recommendations for benefit-risk assessment methodologies and visual representations

(2016) Diana Hughes et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Simultaneous synthesis of treatment effects and mapping to a common scale: an alternative to standardisation

(2015) A. E. Ades et al.   Research Synthesis Methods

Rejoinder to the discussion of “a Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons,” by S. Dias and A. E. Ades

(2015) Hwanhee Hong et al.   Research Synthesis Methods

Absolute or relative effects? Arm-based synthesis of trial data

(2015) S. Dias et al.   Research Synthesis Methods

Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?

(2015) Alberto Gajofatto et al.   World Journal of Clinical Cases

Joint synthesis of multiple correlated outcomes in networks of interventions

(2014) O. Efthimiou et al.   BIOSTATISTICS

Network meta-analysis of multiple outcome measures accounting for borrowing of information across outcomes

(2014) Felix A Achana et al.   BMC Medical Research Methodology

Review of mixed treatment comparisons in published systematic reviews shows marked increase since 2009

(2014) Andrew W. Lee   JOURNAL OF CLINICAL EPIDEMIOLOGY

A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis

(2014) T. L. Vollmer et al.   JOURNAL OF NEUROLOGY

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

(2014) Peter A Calabresi et al.   LANCET NEUROLOGY

Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

(2014) Shahrul Mt-Isa et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios

(2014) Orestis Efthimiou et al.   STATISTICS IN MEDICINE

Simultaneous Multioutcome Synthesis and Mapping of Treatment Effects to a Common Scale

(2014) Guobing Lu et al.   VALUE IN HEALTH

Synthesis of evidence on heterogeneous interventions with multiple outcomes recorded over multiple follow-up times reported inconsistently: a smoking cessation case-study

(2013) Jason Madan et al.   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY

Comparing Bayesian and Frequentist Approaches for Multiple Outcome Mixed Treatment Comparisons

(2013) Hwanhee Hong et al.   MEDICAL DECISION MAKING

Evidence Synthesis for Decision Making 4

(2013) Sofia Dias et al.   MEDICAL DECISION MAKING

Multivariate meta-analysis of mixed outcomes: a Bayesian approach

(2013) Sylwia Bujkiewicz et al.   STATISTICS IN MEDICINE

Evidence Synthesis for Decision Making 2

(2012) Sofia Dias et al.   MEDICAL DECISION MAKING

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

(2012) Giancarlo Comi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

(2012) Robert J. Fox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

(2012) Ralf Gold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

(2011) Paul O'Connor et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multivariate meta-analysis: Potential and promise

(2011) Dan Jackson et al.   STATISTICS IN MEDICINE

Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1

(2011) Jeroen P. Jansen et al.   VALUE IN HEALTH

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

(2010) Georgia Salanti et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

(2010) Ludwig Kappos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Generating random correlation matrices based on vines and extended onion method

(2009) Daniel Lewandowski et al.   JOURNAL OF MULTIVARIATE ANALYSIS

Multivariate meta-analysis: the effect of ignoring within-study correlation

(2009) Richard D. Riley   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY

250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

(2009) Paul O'Connor et al.   LANCET NEUROLOGY

Efficacy of treatment of MS with IFN -1b or glatiramer acetate by monthly brain MRI in the BECOME study

(2009) D. Cadavid et al.   NEUROLOGY

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

(2008) Daniel D Mikol et al.   LANCET NEUROLOGY

Mixed treatment comparison with multiple outcomes reported inconsistently across trials: Evaluation of antivirals for treatment of influenza A and B

(2008) N. J. Welton et al.   STATISTICS IN MEDICINE